Skip to main content

JPMORGAN CHASE & CO

Position in RARE — Ultragenyx Pharmaceutical Inc.

CIK 19617 NEW YORK, NY

Position in RARE

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$16,465,475
+$11,313,285 QoQ
Shares Held
493,126
+100.5% QoQ
Ownership
0.500%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#44
of 311 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 70% Shared 0% None 30%

Common Shares in RARE Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

JPMORGAN CHASE & CO holds $12,940,196,194 across 425 Biotechnology names. RARE ranks #68 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in RARE

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $16,465,475 493,126
2026-03-31 $5,152,190 245,928
2025-12-31 $91,402,690 3,974,030
2025-09-30 $120,663,782 4,011,429
2025-06-30 $118,565,158 3,260,868
2025-03-31 $11,205,941 309,471
2024-12-31 $8,657,457 205,787
2024-09-30 $11,843,813 213,210
2024-06-30 $9,084,124 221,025
2024-03-31 $11,773,348 252,160
2023-12-31 $13,291,185 277,942
2023-09-30 $9,824,817 275,591
2023-06-30 $14,445,377 313,145
2023-03-31 $11,591,625 289,068
2022-12-31 $13,673,650 295,155
2022-09-30 $12,951,844 312,771
2022-06-30 $17,597,133 294,957
2022-03-31 $21,869,003 301,143
2021-12-31 $27,039,474 321,554
2021-09-30 $27,981,535 310,251
2021-06-30 $33,460,125 350,919
2021-03-31 $34,895,697 306,479
2020-12-31 $32,036,853 231,430
2020-09-30 $15,285,200 185,974
2020-06-30 $11,663,147 149,107
2020-03-31 $4,963,273 111,710